Viking Therapeutics, Inc.

LSE:0VQA Stock Report

Market Cap: US$3.2b

Viking Therapeutics Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

LSE:0VQA Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
31 Mar 25BuyUS$29,943Sarah RouanIndividual1,240US$24.15
06 Jan 25SellUS$2,150,595Gregory ZanteIndividual50,309US$43.32
06 Jan 25SellUS$8,313,601Brian LianIndividual194,490US$43.32
06 Jan 25SellUS$2,317,599Marianne ManciniIndividual54,215US$43.32
30 Jul 24SellUS$6,670,604Brian LianIndividual115,859US$58.78
30 Jul 24SellUS$1,029,912Marianne ManciniIndividual18,026US$57.82
30 Jul 24SellUS$922,212Gregory ZanteIndividual16,136US$58.71

Insider Trading Volume

Insider Buying: 0VQA insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of 0VQA?
Owner TypeNumber of SharesOwnership Percentage
State or Government48,6300.0433%
Individual Insiders2,385,5162.12%
General Public30,904,22927.5%
Institutions78,971,17070.3%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.

Top Shareholders

Top 25 shareholders own 52.42% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
10%
FMR LLC
11,248,707US$319.8m-32.7%0.02%
9.05%
The Vanguard Group, Inc.
10,164,257US$289.0m-0.08%no data
5.32%
BlackRock, Inc.
5,976,468US$169.9m1.76%no data
3.61%
State Street Global Advisors, Inc.
4,055,418US$115.3m-17.7%no data
2.57%
Morgan Stanley, Investment Banking and Brokerage Investments
2,886,020US$82.0m19.7%0.01%
2.46%
JP Morgan Asset Management
2,762,460US$78.5m31.8%0.01%
1.77%
Geode Capital Management, LLC
1,984,389US$56.4m5.51%no data
1.71%
Pictet Asset Management Limited
1,921,436US$54.6m55.3%0.04%
1.71%
Brian Lian
1,920,482US$54.6m0.58%no data
1.49%
Susquehanna International Group, LLP, Asset Management Arm
1,676,804US$47.7m62.3%0.07%
1.47%
Citadel Advisors LLC
1,651,090US$46.9m11.2%0.05%
1.47%
Balyasny Asset Management L.P.
1,648,628US$46.9m91.6%0.12%
1.28%
Braidwell LP
1,435,955US$40.8m-2.95%2.05%
1.26%
Columbia Management Investment Advisers, LLC
1,418,123US$40.3m-4.15%0.01%
1.14%
Norges Bank Investment Management
1,278,928US$36.4m0%no data
0.94%
UBS Asset Management AG
1,059,992US$30.1m-1.99%no data
0.93%
AllianceBernstein L.P.
1,039,417US$29.6m-6.78%0.01%
0.63%
Charles Schwab Investment Management, Inc.
711,897US$20.2m-2.3%no data
0.58%
Raymond James Financial Inc., Asset Management Arm
647,391US$18.4m4.68%0.01%
0.56%
ClearBridge Investments, LLC
631,960US$18.0m-1.27%0.01%
0.53%
Principal Global Investors, LLC
598,477US$17.0m-4.87%0.01%
0.53%
Connor, Clark & Lunn Investment Management Ltd.
597,515US$17.0m59.2%0.07%
0.48%
Northern Trust Global Investments
538,636US$15.3m0.49%no data
0.45%
Perceptive Advisors LLC
509,005US$14.5m-48.9%0.55%
0.45%
BNP Paribas Arbitrage Sa, Asset Management Arm
504,716US$14.3m981%0.01%

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/05/19 20:55
End of Day Share Price 2025/05/19 00:00
Earnings2025/03/31
Annual Earnings2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Viking Therapeutics, Inc. is covered by 30 analysts. 17 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Matthew LuchiniBMO Capital Markets Equity Research
Mayank MamtaniB. Riley Securities, Inc.
William FrohnhoeferBTIG